mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
0.9 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
1 |